CLINICAL_TRIALS
trial_result
· 2026-02-10
Clinical Trial Update: Study of ATX-01 in Participants With DM1 [Phase 1, Phase 2]
Summary
ARTHEx Biotech is conducting a Phase 1/2 trial of ATX-01 in participants with Myotonic Dystrophy Type 1, and recruitment is currently ongoing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ARTHEx Biotech S.L. | Conditions: Myotonic Dystrophy 1 | Phase 1, Phase 2 | Status: RECRUITING